The role of innate and adaptive immunity in Parkinson's disease.
about
Differential Co-Expression between α-Synuclein and IFN-γ Signaling Genes across Development and in Parkinson’s DiseaseGenetic perspective on the role of the autophagy-lysosome pathway in Parkinson diseaseGenetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathiesp38 MAPK and PI3K/AKT Signalling Cascades inParkinson's DiseaseThe complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's diseaseAmphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicityInterleukin-6 regulates iron-related proteins through c-Jun N-terminal kinase activation in BV2 microglial cell linesEryptosis as a marker of Parkinson's diseaseNaturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases.Can the disease course in Parkinson's disease be slowed?A Systems Biology Approach to the Coordination of Defensive and Offensive Molecular Mechanisms in the Innate and Adaptive Host-Pathogen Interaction Networks.Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.Microglial M1/M2 polarization and metabolic states.Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model.Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology.Trans-pQTL study identifies immune crosstalk between Parkinson and Alzheimer lociGenomics implicates adaptive and innate immunity in Alzheimer's and Parkinson's diseases.Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases.Engaging cognitive circuits to promote motor recovery in degenerative disorders. exercise as a learning modalityThe role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.LRRK2 and the Immune System.The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma.Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity.A Novel Immunosuppressor, (5R)-5-Hydroxytriptolide, Alleviates Movement Disorder and Neuroinflammation in a 6-OHDA Hemiparkinsonian Rat Model.The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation.Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson's Disease: Rationale for Clinical Trial, and Current Progress.Minimally Toxic Dose of Lipopolysaccharide and α-Synuclein Oligomer Elicit Synergistic Dopaminergic Neurodegeneration: Role and Mechanism of Microglial NOX2 Activation.Peripheral Lymphocyte Subsets as a Marker of Parkinson's Disease in a Chinese Population.Nonhuman Primate Models of Neurodegenerative Disorders.Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.OX40 Gene and Serum Protein Expression Profiles in Patients with Parkinson's Disease.Circulating Neurotoxic 5-HT2A Receptor Agonist Autoantibodies in Adult Type 2 Diabetes with Parkinson’s Disease.Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease.Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cellsEpothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson's Disease
P2860
Q21090572-8E427A14-B12E-433B-AD69-9F281F0BE706Q22242985-A8D49BAF-572B-4CF1-B6C4-487094B722C1Q26767289-9717A76E-24E9-4E59-9691-54D7FAD0D089Q26799375-52E00E60-3031-4A19-8BAB-D6BD197179E5Q26853537-76FCDEF9-874C-4FCA-8BD4-F8665B46358DQ28388234-FBDE819C-8647-4B89-A028-C8BE80E5BC9EQ33866033-D59F720A-7F9F-4874-AF31-A8569DF36074Q34585744-1051989F-A4AD-4CC3-86E6-ECCD0E93682BQ34627859-9B7D37B8-B26D-4B18-9B66-67F8454FEA28Q35627153-80FEDC10-D254-4349-8F29-22852DEACD07Q35865171-9C498C3B-6BB3-47AC-8AED-ABD379201BCEQ35924938-9EC83CFD-21ED-4B6B-934A-00D514D2BE2BQ36212145-71456ADD-F590-4700-BBC8-B470F16AFCD4Q36547001-0C1DBF45-E24F-42E8-BA96-46B2F3013DFEQ37057806-E5537728-E36B-4D1F-A9A6-40ACB849FC5DQ37129119-207B55A7-4AD4-40D0-B62F-94685AD0C247Q37129602-EB669EF3-B7C8-417B-A2EA-7F627866EF11Q37577887-56989590-2C92-451A-8EF5-49CBECA093E3Q37596779-8AFFBB54-67EC-44D6-8A9A-BA8495B6D71AQ38556918-A204A0BB-0A55-4725-B309-366F07E9C711Q38912869-7FEC581A-57A3-47A8-B5AF-E4D28057D710Q38974101-9B2C2745-66D7-4D88-8D14-004CF61002B8Q39114310-519D2272-7A50-47D6-94C3-3B9E83F44C81Q39192172-A5F728D6-913B-4242-B02C-2038FB3A2D3EQ39206438-C3712621-1622-4599-986B-DDE0286C47D7Q39449147-D80210B2-2611-405C-8E1A-9C32A76FCD7AQ40768273-D229F9FC-DD1D-416F-A7AF-EDB9F6FD28C2Q41229954-EB5B994E-679D-4E20-93E9-0870E8661B83Q42048890-878CC6CF-454F-4D37-84DB-D92A85BF4F5FQ42355152-67B19C84-99B2-4643-ADF4-BA7D042B608AQ45201060-F2B97ACC-FFE9-44FB-856E-EE1868116F76Q46445900-63D0D598-7C41-447F-97E4-77037BB0A10BQ47672476-735559C6-F6CA-4780-9D2F-71A6202E5B63Q47687033-BBD1A687-5D74-482D-A5AF-087143D8B74AQ51767077-5A35056E-4DD3-4A5B-8D15-4BA8CBBEFD1AQ52596988-4031F12E-F0F6-4ED8-A2AF-53725C396636Q55017059-F49B72B8-4101-456B-B777-496B920E3871Q55226753-153AFA65-30EA-42C3-9D53-03518E6933D2Q57183034-76E4CA83-42C8-46E6-A62C-CBA8DE5BDDD2Q57490051-688BBD92-1F17-4637-B75D-3141584D390D
P2860
The role of innate and adaptive immunity in Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The role of innate and adaptive immunity in Parkinson's disease.
@en
type
label
The role of innate and adaptive immunity in Parkinson's disease.
@en
prefLabel
The role of innate and adaptive immunity in Parkinson's disease.
@en
P2860
P356
P1476
The role of innate and adaptive immunity in Parkinson's disease.
@en
P2093
George T Kannarkat
Jeremy M Boss
P2860
P304
P356
10.3233/JPD-130250
P577
2013-01-01T00:00:00Z